Gyre Therapeutics (GYRE) Preferred Stock Liabilities (2012 - 2026)
Gyre Therapeutics (GYRE) reported Preferred Stock Liabilities of $44.86 million for Q2 2026, down 63.6% from $123.33 million a year earlier and down 65.9% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Preferred Stock Liabilities (2012 - 2026) Analysis & Trends
At the end of FY2025, Gyre Therapeutics posted Preferred Stock Liabilities of $128.81 million, up 9.1% from FY2024.
- Preferred Stock Liabilities has increased for three consecutive years, with a three-year compound annual growth rate of 57.0% (FY2022 to FY2025).
- By year, Preferred Stock Liabilities came in at $118.11 million in FY2024 (+83.0%), $64.53 million in FY2023 (+93.7%) and $33.31 million in FY2022.
- The Q2 2026 figure ranks as the lowest quarterly Preferred Stock Liabilities since Q2 2023.
- Year over year, Preferred Stock Liabilities gained in three of the last four quarters, with growth averaging 9.4%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Gyre Therapeutics | 487.81 Mn | 295.13 Mn | 30.99 Mn | 43.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 43.10 Mn |
| Jun 30, 2026 | 22.43 Mn |
| Mar 31, 2026 | 131.66 Mn |
| Dec 31, 2025 | 128.81 Mn |
| Sep 30, 2025 | 126.04 Mn |
| Jun 30, 2025 | 123.33 Mn |
| Mar 31, 2025 | 120.69 Mn |
| Dec 31, 2024 | 118.11 Mn |
| Sep 30, 2024 | 64.53 Mn |
| Jun 30, 2024 | 64.53 Mn |
| Mar 31, 2024 | 64.53 Mn |
| Dec 31, 2023 | 64.53 Mn |
| Sep 30, 2023 | 33.31 Mn |
| Jun 30, 2023 | 33.31 Mn |
| Mar 31, 2023 | 33.31 Mn |
| Dec 31, 2022 | 33.31 Mn |
| Dec 31, 2014 | 108.88 Mn |
| Dec 31, 2013 | 104.64 Mn |
| Dec 31, 2012 | 98.90 Mn |
API Access
Gyre Therapeutics Preferred Stock Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "preferred-stock-liabilities", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();